DR LAL PATHLABS LTD INR 10.0 144A's ticker is and the CUSIP is Y2R0AQ143. A total of 1 filers reported holding DR LAL PATHLABS LTD INR 10.0 144A in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,584,000 | +17.2% | 69,974 | 0.0% | 0.43% | +9.5% |
| Q4 2020 | $2,204,000 | +23.6% | 69,974 | 0.0% | 0.39% | -0.8% |
| Q3 2020 | $1,783,000 | +109.3% | 69,974 | +70.3% | 0.39% | +91.7% |
| Q2 2020 | $852,000 | +11.8% | 41,082 | 0.0% | 0.20% | -11.3% |
| Q1 2020 | $762,000 | – | 41,082 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stanley-Laman Group, Ltd. | 69,974 | $2,204,000 | 0.39% |